Home › Cancer (all types) › NCT04075305
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patient is to undergo or has completed imaging or treatment procedures on an MR-Linac; * Patient provides written, informed consent; * Patient is 18 years old or older. Exclusion Criteria: * MRI exclusion criteria, including * MRI contraindications as per usual clinical care, such as (possible) pregnancy; claustrophobia and metal or electronic implants not compatible with MRI.
About the study
The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients' survival, local, and regional tumor control and quality of life.
What is being tested
- Radiation therapy (radiation)
Sponsor: UMC Utrecht · Participants: 8,000 · Started: Feb 1, 2019
Contact the study team
- Tessa Leer · Phone: T +31 (0)88 75 63707
Official record on ClinicalTrials.gov — NCT04075305
Locations in the U.S.
| Pennsylvania | Allegheny Health Network, Pittsburgh |
| Texas | Md Anderson Cancer Center, Houston |
| Wisconsin | Medical College of Wisconsin, Milwaukee |
Conditions
- Cancer (all types)
- Breast Cancer
- Prostate Cancer
- Brain Tumors
- Female Genital Cancer
- Radiation Injuries
- Rectal Cancer
- Lung Cancer
- Esophageal Cancer
- Pancreatic Cancer
- Head and Neck Cancer
- Bladder Cancer
- Liver Cancer
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.